Adeno-Associated Virus Delivery Limitations for Neurological Indications

Wirth T , Parker N , Yla-Herttuala S . History of gene therapy. Gene, 2013; 525:162–169.

Reisinger E . Dual-AAV delivery of large gene sequences to the inner ear. Hear Res, 2020; 394:107857.

Wang B , Li J , Xiao X . Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model. Proc Natl Acad Sci U S A, 2000; 97:13714–13719.

Bai RY , Esposito D , Tam AJ , et al. Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors. Gene Ther, 2019; 26:277–286.

Chen C , Ponnusamy M , Liu C , et al. MicroRNA as a therapeutic target in cardiac remodeling. Biomed Res Int, 2017; 2017:1278436.

Geisler A , Schön C , Größl T , et al. Application of mutated miR-206 target sites enables skeletal muscle-specific silencing of transgene expression of cardiotropic AAV9 vectors. Mol Ther, 2013; 21:924–933.

Powell SK , Samulski RJ , McCown TJ . AAV Capsid-promoter interactions determine CNS cell-selective gene expression in vivo. Mol Ther, 2020; 28:1373–1380.

Fang YX , Zhang XB , Wei W , et al. Development of chimeric gene regulators for cancer-specific gene therapy with both transcriptional and translational targeting. Mol Biotechnol, 2010; 45:71–81.

Powell SK , Rivera-Soto R , Gray SJ . Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy. Discov Med, 2015; 19:49–57.

Muhuri M , Zhan W , Maeda Y , et al. Novel combinatorial MicroRNA-binding sites in AAV vectors synergistically diminish antigen presentation and transgene immunity for efficient and stable transduction. Front Immunol, 2021; 12:674242.

Garcia-Linares C , Fernández-Rodríguez J , Terribas E , et al. Dissecting loss of heterozygosity (LOH) in neurofibromatosis type 1-associated neurofibromas: importance of copy neutral LOH. Hum Mutat, 2011; 32:78–90.

Goertsen D , Flytzanis NC , Goeden N , et al. AAV capsid variants with brain-wide transgene expression and decreased liver targeting after intravenous delivery in mouse and marmoset. Nat Neurosci, 2021; 25:106–115.

Deverman BE , Pravdo PL , Simpson BP , et al. Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nat Biotechnol, 2016; 34:204–209.

Chan KY , Jang MJ , Yoo BB , et al. Engineered AAVs for efficient noninvasive gene delivery to the central and peripheral nervous systems. Nat Neurosci, 2017; 20:1172–1179.

Nonnenmacher M , Wang W , Child MA , et al. Rapid evolution of blood-brain-barrier-penetrating AAV capsids by RNA-driven biopanning. Mol Ther Methods Clin Dev, 2021; 20:366–378.

High KA , Roncarolo MG . Gene therapy. N Engl J Med, 2019; 381:455–464.

Mendell JR , Al-Zaidy SA , Rodino-Klapac LR , et al. Current clinical applications of in vivo gene therapy with AAVs. Mol Ther, 2021; 29:464–488.

Hoy SM . Onasemnogene abeparvovec: first global approval. Drugs, 2019; 79:1255–1262.

Russell S , Bennett J , Wellman JA , et al. Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial. Lancet, 2017; 390:849–860.

Mendell JR , Al-Zaidy S , Shell R , et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med, 2017; 377:1713–1722.

Gray SJ . Gene therapy and neurodevelopmental disorders. Neuropharmacology, 2013; 68:136–142.

Taghian T , Marosfoi MG , Puri AS , et al. A safe and reliable technique for CNS delivery of AAV vectors in the cisterna magna. Mol Ther, 2020; 28:411–421.

Zschaler J , Schlorke D , Arnhold J . Differences in innate immune response between man and mouse. Crit Rev Immunol, 2014; 34:433–454.

Bailey RM , Armao D , Nagabhushan Kalburgi S . et al. Development of intrathecal AAV9 gene therapy for giant axonal neuropathy. Mol Ther Methods Clin Dev, 2018; 9:160–171.

Chakrabarty P , Jansen-West K , Beccard A , et al. Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J, 2010; 24:548–559.

Chakrabarty P , Rosario A , Cruz P , et al. Capsid serotype and timing of injection determines AAV transduction in the neonatal mice brain. PLoS One, 2013; 8:e67680.

Ogawa K , Hirai Y , Ishizaki M , et al. Long-term inhibition of glycosphingolipid accumulation in Fabry model mice by a single systemic injection of AAV1 vector in the neonatal period. Mol Genet Metab, 2009; 96:91–96.

Hardcastle N , Boulis NM , Federici T . AAV gene delivery to the spinal cord: serotypes, methods, candidate diseases, and clinical trials. Expert Opin Biol Ther, 2018; 18:293–307.

Meseck EK , Guibinga G , Wang S , et al. Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques. 2021. https://www.biorxiv.org/content/10.1101/2021.11.28.470258v1.full (last accessed January 10, 2022 ).

Palazzi X , Pardo I , Sirivelu M , et al. Biodistribution and tolerability of AAV-PHP.B-CBh-SMN1 in Wistar Han Rats and cynomolgus macaques reveal different toxicologic profiles. Hum Gene Ther, 2021 Dec 21 [Epub ahead of print]; DOI: 10.1089/hum.2021.116.

Buscara L , Gross DA , Daniele N . Of rAAV and men: from genetic neuromuscular disorder efficacy and toxicity preclinical studies to clinical trials and back. J Pers Med, 2020; 10:258.

Chand DH , Zaidman C , Arya K , et al. Thrombotic microangiopathy following onasemnogene abeparvovec for spinal muscular atrophy: a case series. J Pediatr, 2021; 231:265–268.

Hinderer C , Katz N , Buza EL , et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther, 2018; 29:285–298.

Hordeaux J , Buza EL , Dyer C , et al. Adeno-associated virus-induced dorsal root ganglion pathology. Hum Gene Ther, 2020; 31:808–818.

Bratulic A . Audentes' Gene Therapy AT132 Hit with FDA Clinical Hold After Second Patient Death, Vol. 2021. First Word Pharma, 2020. https://old.firstwordpharma.com/node/1736153 (last accessed January 11, 2022 ).

Passini MA , Bu J , Richards AM , et al. Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Hum Gene Ther, 2014; 25:619–630.

Gray SJ , Nagabhushan Kalburgi S , McCown TJ , et al. Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther, 2013; 20:450–459.

Marco S , Haurigot V , Bosch F . In vivo gene therapy for mucopolysaccharidosis type III (Sanfilippo syndrome): a new treatment horizon. Hum Gene Ther, 2019; 30:1211–1221.

Fowler MJ , Cotter JD , Knight BE , et al. Intrathecal drug delivery in the era of nanomedicine. Adv Drug Deliv Rev, 2020; 165–166:77–95.

Calias P , Banks WA , Begley D , et al. Intrathecal delivery of protein therapeutics to the brain: a critical reassessment. Pharmacol Ther, 2014; 144:114–122.

Guo Y , Wang D , Qiao T , et al. A single injection of recombinant adeno-associated virus into the lumbar cistern delivers transgene expression throughout the whole spinal cord. Mol Neurobiol, 2016; 53:3235–3248.

Ballesteros C , Pouliot M , Froment R , et al. Cerebrospinal fluid characterization in cynomolgus monkeys, beagle dogs, and Gottingen minipigs. Int J Toxicol, 2020; 39:124–130.

Hocking G , Wildsmith JA . Intrathecal drug spread. Br J Anaesth, 2004; 93:568–578.

Korte S , Runge F , Wozniak MM , et al. Range of neurological signs in cynomolgus monkeys after intrathecal bolus administration of antisense oligonucleotides. Int J Toxicol, 2020; 39:505–509.

Hinderer C , Katz N , Dyer C , et al. Translational feasibility of lumbar puncture for intrathecal AAV administration. Mol Ther Methods Clin Dev, 2020; 17:969–974.

Sakka L , Coll G , Chazal J . Anatomy and physiology of cerebrospinal fluid. Eur Ann Otorhinolaryngol Head Neck Dis, 2011; 128:309–316.

Castle MJ , Cheng Y , Asokan A , et al. Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion. Sci Adv, 2018; 4:eaau9859.

Borel F , Adams E , Mueller C . Intrathecal delivery of AAV vectors in cynomolgus macaques for CNS gene therapy and gene expression analysis in microdissected motor neurons. Methods Mol Biol, 2019; 1937:295–303.

Borel F , Gernoux G , Sun H , et al. Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques. Sci Transl Med, 2018; 10:eaau6414.

Donoho DA , Buchanan IA , Rangwala SD , et al. Readmissions after ventricular shunting in pediatric patients with hydrocephalus: a Nationwide Readmissions Database analysis. J Neurosurg Pediatr, 2021; 28:553–562.

Gray-Edwards HL , Randle AN , Maitland SA , et al. Adeno-associated virus gene therapy in a sheep model of Tay-Sachs disease. Hum Gene Ther, 2018; 29:312–326.

Kordasiewicz HB , Stanek LM , Wancewicz EV , et al. Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis. Neuron, 2012; 74:1031–1044.

Samaranch L , Salegio EA , San Sebastian W , et al. Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther, 2012; 23:382–389.

Blits B , Petry H . Perspective on the road toward gene therapy for Parkinson's disease. Front Neuroanat, 2016; 10:128.

Taghian T , Horn E , Shazeeb MS , et al. Volume and infusion rate dynamics of intraparenchymal central nervous system infusion in a large animal model. Hum Gene Ther, 2020; 31:617–625.

Gray-Edwards HL , Regier DS , Shirley JL , et al. Novel biomarkers of human GM1 gangliosidosis reflect the clinical efficacy of gene therapy in a feline model. Mol Ther, 2017; 25:892–903.

Bradbury AM , Peterson TA , Gross AL , et al. AAV-mediated gene delivery attenuates neuroinflammation in feline Sandhoff disease. Neuroscience, 2017; 340:117–125.

Salegio EA , Kells AP , Richardson RM , et al. Magnetic resonance imaging-guided delivery of adeno-associated virus type 2 to the primate brain for the treatment of lysosomal storage disorders. Hum Gene Ther, 2010; 21:1093–1103.

San Sebastian W , Samaranch L , Heller G , et al. Adeno-associated virus type 6 is retrogradely transported in the non-human primate brain. Gene Ther, 2013; 20:1178–1183.

Rockwell HE , McCurdy VJ , Eaton SC , et al. AAV-mediated gene delivery in a feline model of Sandhoff disease corrects lysosomal storage in the central nervous system. ASN Neuro, 2015; 7:1759091415569908.

McCurdy VJ , Johnson AK , Gray-Edwards HL , et al. Sustained normalization of neurological disease after intracranial gene therapy in a feline model. Sci Transl Med, 2014; 6:231ra48.

McCurdy VJ , Johnson AK , Gray-Edwards HL , et al. Therapeutic benefit after intracranial gene therapy delivered during the symptomatic stage in a feline model of Sandhoff disease. Gene Ther, 2021; 28:142–154.

Golebiowski D , van der Bom IMJ , Kwon C-S , et al. Safety study of intracranial AAVrh8-mediated gene transfer of beta-hexosaminidase in non-human primates. Mol Ther, 2013; 21:S149.

Fiandaca MS , Forsayeth JR , Dickinson PJ , et al. Image-guided convection-enhanced delivery platform in the treatment of neurological diseases. Neurotherapeutics, 2008; 5:123–127.

Christine CW , Starr PA , Larson PS , et al. Safety and tolerability of putaminal AADC gene therapy for Parkinson disease. Neurology, 2009; 73:1662–1669.

Yazdan-Shahmorad A , Tian N , Kharazia V , et al. Widespread optogenetic expression in macaque cortex obtained with MR-guided, convection enhanced delivery (CED) of AAV vector to the thalamus. J Neurosci Methods, 2018; 293:347–358.

Fu H , Muenzer J , Samulski RJ , et al. Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain. Mol Ther, 2003; 8:911–917.

Miyanohara A , Kamizato K , Juhas S , et al. Potent spinal parenchymal AAV9-mediated gene delivery by subpial injection in adult rats and pigs. Mol Ther Methods Clin Dev, 2016; 3:16046.

Tadokoro T , Miyanohara A , Navarro M , et al. Subpial adeno-associated virus 9 (AAV9) vector delivery in adult mice. J Vis Exp, 2017; 125:55770.

Marsala M , Kamizato K , Tadokoro T , et al. Spinal parenchymal occupation by neural stem cells after subpial delivery in adult immunodeficient rats. Stem Cells Transl Med, 2020; 9:177–188.

Bravo-Hernandez M , Tadokoro T , Navarro MR , et al. Spinal subpial delivery of AAV9 enables widespread gene silencing and blocks motoneuron degeneration in ALS. Nat Med, 2020; 26:118–130.

Foust KD , Salazar DL , Likhite S , et al. Therapeutic AAV9-mediated suppression of mutant SOD1 slows disease progression and extends survival in models of inherited ALS. Mol Ther, 2013; 21:2148–2159.

Bradbury AM , Rafi MA , Bagel JH , et al. AAVrh10 gene therapy ameliorates central and peripheral nervous system disease in canine globoid cell leukodystrophy (Krabbe disease). Hum Gene Ther, 2018; 29:785–801.

Chamberlain JR , Chamberlain JS . Progress toward gene therapy for Duchenne muscular dystrophy. Mol Ther, 2017; 25:1125–1131.

Yue Y , Shin JH , Duan D . Whole body skeletal muscle transduction in neonatal dogs with AAV-9. Methods Mol Biol, 2011; 709:313–329.

Cotugno G , Annunziata P , Tessitore A , et al. Long-term amelioration of feline mucopolysaccharidosis VI after AAV-mediated liver gene transfer. Mol Ther, 2011; 19:461–469.

Mitchell NL , Russell KN , Wellby MP , et al. Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 batten disease. Mol Ther, 2018; 26:2366–2378.

Isakson SH , Rizzardi AE , Coutts AW , et al. Genetically engineered minipigs model the major clinical features of human neurofibromatosis type 1. Commun Biol, 2018; 1:158.

Osum SH , Coutts AW , Duerre DJ , et al. Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo. Neurooncol Adv, 2021; 3:vdab020.

Eaton SL , Proudfoot C , Lillico SG , et al. CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease). Sci Rep, 2019; 9:9891.

Jacobsen JC , Bawden CS , Rudiger SR , et al. An ovine transgenic Huntington's disease model. Hum Mol Genet, 2010; 19:1873–1882.

Howland D , Ellederova Z , Aronin N , et al. Large animal models of Huntington's disease: what we have learned and where we need to go next. J Huntingtons Dis, 2020; 9:201–216.

Yan S , Tu Z , Liu Z , et al. A Huntingtin Knockin Pig Model recapitulates features of selective neurodegeneration in Huntington's disease. Cell, 2018; 173:989–1002.e13.

Zhu F , Nair RR , Fisher EMC , et al. Humanising the mouse genome piece by piece. Nat Commun, 2019; 10:1845.

Seyrantepe V , Demir SA , Timur ZK , et al. Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse model of Tay-Sachs disease. Exp Neurol, 2018; 299:26–41.

Wang S , Li Y , Xu Y , et al. AAV gene therapy prevents and reverses heart failure in a murine knockout model of barth syndrome. Circ Res, 2020; 126:1024–1039.

Delenclos M , Faroqi AH , Yue M , et al. Neonatal AAV delivery of alpha-synuclein induces pathology in the adult mouse brain. Acta Neuropathol Commun, 2017; 5:51.

Phaneuf D , Wakamatsu N , Huang JQ , et al. Dramatically different phenotypes in mouse models of human Tay-Sachs and Sandhoff diseases. Hum Mol Genet, 1996; 5:1–14.

Oki K , Wei B , Feng HZ , et al. The loss of slow skeletal muscle isoform of troponin T in spindle intrafusal fibres explains the pathophysiology of Amish nemaline myopathy. J Physiol, 2019; 597:3999–4012.

Campen CJ , Gutmann DH . Optic pathway gliomas in neurofibromatosis type 1. J Child Neurol, 2018; 33:73–81.

Rangarajan S , Walsh L , Lester W , et al. AAV5-factor VIII gene transfer in severe hemophilia A. N Engl J Med, 2017; 377:2519–2530.

Friese J , Geitmann S , Holzwarth D , et al. Safety monitoring of gene therapy for spinal muscular atrophy with onasemnogene abeparvovec-a single centre experience. J Neuromuscul Dis, 2021; 8:209–216.

Mueller C , Berry JD , McKenna-Yasek DM , et al. SOD1 suppression with adeno-associated virus and microRNA in familial ALS. N Engl J Med, 2020; 383:151–158.

Gougeon ML , Poirier-Beaudouin B , Ausseil J , et al. Cell-mediated immunity to NAGLU transgene following intracerebral gene therapy in children with mucopolysaccharidosis type IIIB syndrome. Front Immunol, 2021; 12:655478.

Blinkov SM , Glezer II . The Human Brain in Figures and Tables. A Quantitative Handbook. New York: Plenum Press, 1968.

Nieuwenhuys R , Ten Donkelaar HJ , Nicholson C . The Central Nervous System of Vertebrates. Berlin: Springer, 1998.

Thomas CE , Combs CM . Spinal Cord Segments. B. Gross structure in the adult monkey. Am J Anat, 1965; 116:205–216.

Sakane T , Okabayashi S , Kimura S , et al. Brain and nasal cavity anatomy of the cynomolgus monkey: species differences from the viewpoint of direct delivery from the nose to the brain. Pharmaceutics, 2020; 12:1227.

Lu Y , Barton HA , Leung L , et al. Cerebrospinal fluid beta-amyloid turnover in the mouse, dog, monkey and human evaluated by systematic quantitative analyses. Neurodegener Dis, 2013; 12:36–50.

Sullivan JM , Mazur C , Wolf DA , et al. Convective forces increase rostral delivery of intrathecal radiotracers and antisense oligonucleotides in the cynomolgus monkey nervous system. J Transl Med, 2020; 18:309.

Choi K , Chang J , Lee M-J , et al. Reference values of hematology, biochemistry, and blood type in cynomolgus monkeys from cambodia origin. Lab Anim Res, 2016; 32:46–55.

Morgan CJ , Pyne-Geithman GJ , Jauch EC , et al. Bilirubin as a cerebrospinal fluid marker of sentinel subarachnoid hemorrhage: a preliminary report in pigs. J Neurosurg, 2004; 101:1026–1029.

Bernards CM . Cerebrospinal fluid and spinal cord distribution of baclofen and bupivacaine during slow intrathecal infusion in pigs. Anesthesiology, 2006; 105:169–178.

Busscher I , Ploegmakers JJ , Verkerke GJ , et al. Comparative anatomical dimensions of the complete human and porcine spine. Eur Spine J, 2010; 19:1104–1114.

Greenaway JB , Partlow GD , Gonsholt NL , et al. Anatomy of the lumbosacral spinal cord in rabbits. J Am Anim Hosp Assoc, 2001; 37:27–34.

Piao Y , Liu Y , Xie X . Change trends of organ weight background data in sprague dawley rats at different ages. J Toxicol Pathol, 2013; 26:29–34.

de Sousa BN , Horrocks LA . Development of rat spinal cord. Dev Neurosci, 1979; 2:7.

Pardridge WM . Drug transport in brain via the cerebrospinal fluid. Fluids Barriers CNS, 2011; 8:7.